{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-039020","form_type":"8-K","ticker":"ANGO","cik":"0001275187","company_name":"ANGIODYNAMICS INC","filed_at":"2026-10-08T11:17:49+00:00","discovered_at":"2026-10-08T11:20:00.289364+00:00","generated_at":"2026-10-12T15:38:15.551451+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"AngioDynamics Q1 FY27 sales rise 6.9% to $80.9M; adjusted loss narrows to $0.04, FY27 guidance reiterated","bullets":["Net sales $80.9M, up 6.9% YoY; Med Tech $39.9M (+13.2%) and Med Device $41.0M (+1.4%); GAAP loss per share $0.17 vs $0.26 a year ago.","Adjusted loss per share $0.04 vs $0.10; adjusted EBITDA $5.0M vs $2.2M; gross margin 59.4% (+410 bps), or 57.8% excluding tariff refunds; $34.0M cash, debt-free.","Auryon sales $18.9M (+14.7%), NanoKnife $8.3M (+29.0%), AlphaVac +37.4%, AngioVac -5.9%; Mechanical Thrombectomy $12.0M (+6.7%).","FY27 guidance reiterated: net sales $336-341M, Med Tech growth 12-15%, Med Device flat, gross margin 54-55%, adjusted EBITDA $13-16M, adjusted EPS -$0.29 to -$0.24.","Eric Honroth named President and CEO effective Nov 2, 2026, succeeding retiring Jim Clemmer; FDA IDE approved for RELIEF, a 40-patient NanoKnife IRE study in BPH."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-039020","json":"https://secwatch.observer/filing/0001140361-26-039020.json","markdown":"https://secwatch.observer/filing/0001140361-26-039020.md","text":"https://secwatch.observer/filing/0001140361-26-039020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126039020/0001140361-26-039020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126039020/ef20083493_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T15:38:15.551451+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}